Invention Grant
US08808999B2 Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof
有权
抗IGF-1R和/或抗胰岛素/ IGF-I杂合受体抗体及其用途
- Patent Title: Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof
- Patent Title (中): 抗IGF-1R和/或抗胰岛素/ IGF-I杂合受体抗体及其用途
-
Application No.: US13352599Application Date: 2012-01-18
-
Publication No.: US08808999B2Publication Date: 2014-08-19
- Inventor: Liliane Goetsch , Nathalie Corvaia , Alain Duflos , Jean-Francois Haeuw , Olivier Leger , Alain Beck
- Applicant: Liliane Goetsch , Nathalie Corvaia , Alain Duflos , Jean-Francois Haeuw , Olivier Leger , Alain Beck
- Applicant Address: FR Boulogne-Billancourt
- Assignee: Pierre Fabre Medicament
- Current Assignee: Pierre Fabre Medicament
- Current Assignee Address: FR Boulogne-Billancourt
- Agency: Buchanan Ingersoll & Rooney PC
- Priority: FR0200653 20020118; FR0200654 20020118; FR0205753 20020507; FR0308538 20030711
- Main IPC: C07K14/72
- IPC: C07K14/72 ; C07K16/28
Abstract:
The present invention relates to methods of identifying IGF-IR modulators and hybrid-R modulators comprising contacting IGF-IR with a humanized anti-IGF-IR antibody and contacting hybrid-R with a humanized anti-hybrid-R antibody, respectively.
Public/Granted literature
- US20120208721A1 NOVEL ANTI-IGF-IR AND/OR ANTI-INSULIN/IGF-I HYBRID RECEPTORS ANTIBODIES AND USES THEREOF Public/Granted day:2012-08-16
Information query
